- Home
- KXIN vs XXII Comparison
KXIN vs XXII Comparison
Compare KXIN & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KXIN
- XXII
- Stock Information
- Founded
- KXIN 2015
- XXII 1998
- Country
- KXIN China
- XXII United States
- Employees
- KXIN N/A
- XXII N/A
- Industry
- KXIN Retail-Auto Dealers and Gas Stations
- XXII Medicinal Chemicals and Botanical Products
- Sector
- KXIN Consumer Discretionary
- XXII Health Care
- Exchange
- KXIN Nasdaq
- XXII Nasdaq
- Market Cap
- KXIN 2.8M
- XXII 2.8M
- IPO Year
- KXIN N/A
- XXII N/A
- Fundamental
- Price
- KXIN $1.60
- XXII $5.10
- Analyst Decision
- KXIN
- XXII
- Analyst Count
- KXIN 0
- XXII 0
- Target Price
- KXIN N/A
- XXII N/A
- AVG Volume (30 Days)
- KXIN 900.6K
- XXII 2.5M
- Earning Date
- KXIN 01-01-0001
- XXII 11-12-2024
- Dividend Yield
- KXIN N/A
- XXII N/A
- EPS Growth
- KXIN N/A
- XXII N/A
- EPS
- KXIN N/A
- XXII N/A
- Revenue
- KXIN $12,679,000.00
- XXII $17,304,000.00
- Revenue This Year
- KXIN N/A
- XXII $56.94
- Revenue Next Year
- KXIN N/A
- XXII $2.98
- P/E Ratio
- KXIN N/A
- XXII N/A
- Revenue Growth
- KXIN N/A
- XXII N/A
- 52 Week Low
- KXIN $1.20
- XXII $3.90
- 52 Week High
- KXIN $51.00
- XXII $581.85
- Technical
- Relative Strength Index (RSI)
- KXIN 42.58
- XXII 41.23
- Support Level
- KXIN $1.46
- XXII $4.80
- Resistance Level
- KXIN $1.65
- XXII $12.49
- Average True Range (ATR)
- KXIN 0.27
- XXII 2.00
- MACD
- KXIN 0.07
- XXII 0.36
- Stochastic Oscillator
- KXIN 30.77
- XXII 3.90
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.